|
1 Indications And Usage Udenyca Is Indicated To Decrease The Incidence Of Infection, As Manifested By Febrile Neutropenia, In Patients With Non-Myeloid Malignancies Receiving Myelosuppressive Anti-Cancer Drugs Associated With A Clinically Significant Incidence Of Febrile Neutropenia [See Clinical Studies ( 14 )] . Limitations Of Use Udenyca Is Not Indicated For The Mobilization Of Peripheral Blood Progenitor Cells For Hematopoietic Stem Cell Transplantation. Udenyca Is A Leukocyte Growth Factor Indicated To Decrease The Incidence Of Infection, As Manifested By Febrile Neutropenia, In Patients With Non-Myeloid Malignancies Receiving Myelosuppressive Anti-Cancer Drugs Associated With A Clinically Significant Incidence Of Febrile Neutropenia. ( 1 ) Limitations Of Use Udenyca Is Not Indicated For The Mobilization Of Peripheral Blood Progenitor Cells For Hematopoietic Stem Cell Transplantation.
|